Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts

• Shigeo Muro,
• Hisatoshi Sugiura,
• Patrick Darken,
• Paul Dorinsky

Affiliations

Shigeo Muro

Department of Respiratory Medicine, Nara Medical University Graduate School of Medicine

Hisatoshi Sugiura

Department of Respiratory Medicine, Tohoku University Graduate School of Medicine

Patrick Darken

AstraZeneca

Paul Dorinsky

AstraZeneca